Annual EBITDA
$1.10 B
+$85.40 M+8.44%
31 December 2023
Summary:
IDEXX Laboratories annual earnings before interest, taxes, depreciation & amortization is currently $1.10 billion, with the most recent change of +$85.40 million (+8.44%) on 31 December 2023. During the last 3 years, it has risen by +$306.02 million (+38.68%). IDXX annual EBITDA is now at all-time high.IDXX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$340.74 M
+$41.39 M+13.83%
30 September 2024
Summary:
IDEXX Laboratories quarterly earnings before interest, taxes, depreciation & amortization is currently $340.74 million, with the most recent change of +$41.39 million (+13.83%) on 30 September 2024. Over the past year, it has increased by +$35.22 million (+11.53%). IDXX quarterly EBITDA is now at all-time high.IDXX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$1.25 B
+$35.22 M+2.89%
30 September 2024
Summary:
IDEXX Laboratories TTM earnings before interest, taxes, depreciation & amortization is currently $1.25 billion, with the most recent change of +$35.22 million (+2.89%) on 30 September 2024. Over the past year, it has increased by +$57.57 million (+4.82%). IDXX TTM EBITDA is now at all-time high.IDXX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IDXX EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.4% | +11.5% | +4.8% |
| 3 y3 years | +38.7% | +34.9% | +22.8% |
| 5 y5 years | +90.6% | +109.9% | +95.9% |
IDXX EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +38.7% | at high | +64.2% | at high | +30.1% |
| 5 y | 5 years | at high | +90.6% | at high | +146.0% | at high | +95.9% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
IDEXX Laboratories EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $340.74 M(+13.8%) | $1.25 B(+2.9%) |
| June 2024 | - | $299.35 M(-10.2%) | $1.22 B(-2.0%) |
| Mar 2024 | - | $333.29 M(+19.6%) | $1.24 B(+2.0%) |
| Dec 2023 | $1.10 B(+8.4%) | $278.67 M(-8.8%) | $1.22 B(+1.9%) |
| Sept 2023 | - | $305.52 M(-5.8%) | $1.19 B(+2.7%) |
| June 2023 | - | $324.33 M(+4.9%) | $1.16 B(+11.2%) |
| Mar 2023 | - | $309.15 M(+21.0%) | $1.05 B(+3.4%) |
| Dec 2022 | $1.01 B(-2.4%) | $255.48 M(-6.7%) | $1.01 B(+2.9%) |
| Sept 2022 | - | $273.73 M(+31.9%) | $983.30 M(+2.2%) |
| June 2022 | - | $207.52 M(-24.5%) | $962.13 M(-7.4%) |
| Mar 2022 | - | $275.00 M(+21.1%) | $1.04 B(+0.2%) |
| Dec 2021 | $1.04 B(+31.1%) | $227.06 M(-10.1%) | $1.04 B(+1.7%) |
| Sept 2021 | - | $252.55 M(-11.3%) | $1.02 B(+5.8%) |
| June 2021 | - | $284.72 M(+4.4%) | $963.99 M(+7.6%) |
| Mar 2021 | - | $272.73 M(+30.0%) | $896.17 M(+13.3%) |
| Dec 2020 | $791.11 M(+23.4%) | $209.82 M(+6.7%) | $791.11 M(+9.9%) |
| Sept 2020 | - | $196.72 M(-9.3%) | $719.77 M(+5.0%) |
| June 2020 | - | $216.90 M(+29.4%) | $685.39 M(+4.7%) |
| Mar 2020 | - | $167.67 M(+21.1%) | $654.42 M(+2.0%) |
| Dec 2019 | $641.28 M(+11.4%) | $138.49 M(-14.7%) | $641.28 M(+0.4%) |
| Sept 2019 | - | $162.33 M(-12.7%) | $639.00 M(+3.9%) |
| June 2019 | - | $185.93 M(+20.3%) | $615.04 M(+3.2%) |
| Mar 2019 | - | $154.53 M(+13.5%) | $595.77 M(+3.5%) |
| Dec 2018 | $575.66 M(+14.8%) | $136.21 M(-1.6%) | $575.66 M(+2.7%) |
| Sept 2018 | - | $138.37 M(-17.0%) | $560.38 M(+2.9%) |
| June 2018 | - | $166.66 M(+24.0%) | $544.55 M(+4.3%) |
| Mar 2018 | - | $134.43 M(+11.2%) | $522.22 M(+4.1%) |
| Dec 2017 | $501.42 M(+16.0%) | $120.92 M(-1.3%) | $501.42 M(+3.3%) |
| Sept 2017 | - | $122.54 M(-15.1%) | $485.62 M(+2.9%) |
| June 2017 | - | $144.33 M(+27.0%) | $472.16 M(+4.3%) |
| Mar 2017 | - | $113.63 M(+8.1%) | $452.59 M(+4.7%) |
| Dec 2016 | $432.11 M(+16.4%) | $105.12 M(-3.6%) | $432.11 M(+4.8%) |
| Sept 2016 | - | $109.08 M(-12.6%) | $412.43 M(+4.6%) |
| June 2016 | - | $124.75 M(+33.9%) | $394.21 M(+5.1%) |
| Mar 2016 | - | $93.16 M(+9.0%) | $375.11 M(+1.0%) |
| Dec 2015 | $371.34 M(+15.7%) | $85.44 M(-6.0%) | $371.34 M(+10.4%) |
| Sept 2015 | - | $90.86 M(-14.0%) | $336.43 M(+0.9%) |
| June 2015 | - | $105.65 M(+18.2%) | $333.59 M(+2.2%) |
| Mar 2015 | - | $89.38 M(+76.9%) | $326.34 M(+1.7%) |
| Dec 2014 | $320.87 M(-0.7%) | $50.54 M(-42.6%) | $320.87 M(-7.2%) |
| Sept 2014 | - | $88.02 M(-10.5%) | $345.67 M(+2.5%) |
| June 2014 | - | $98.40 M(+17.3%) | $337.36 M(+1.6%) |
| Mar 2014 | - | $83.91 M(+11.4%) | $332.01 M(+2.7%) |
| Dec 2013 | $323.24 M(+2.0%) | $75.33 M(-5.5%) | $323.24 M(-0.8%) |
| Sept 2013 | - | $79.71 M(-14.3%) | $325.77 M(+1.1%) |
| June 2013 | - | $93.05 M(+23.8%) | $322.24 M(+1.2%) |
| Mar 2013 | - | $75.14 M(-3.5%) | $318.47 M(+0.5%) |
| Dec 2012 | $316.87 M(+10.7%) | $77.86 M(+2.2%) | $316.87 M(+3.0%) |
| Sept 2012 | - | $76.18 M(-14.7%) | $307.63 M(+2.5%) |
| June 2012 | - | $89.28 M(+21.4%) | $300.04 M(+1.9%) |
| Mar 2012 | - | $73.55 M(+7.2%) | $294.35 M(+2.9%) |
| Dec 2011 | $286.17 M(+14.2%) | $68.62 M(+0.0%) | $286.17 M(+2.0%) |
| Sept 2011 | - | $68.59 M(-17.9%) | $280.53 M(+2.6%) |
| June 2011 | - | $83.60 M(+27.9%) | $273.38 M(+6.7%) |
| Mar 2011 | - | $65.36 M(+3.8%) | $256.14 M(+2.3%) |
| Dec 2010 | $250.50 M(+10.7%) | $62.98 M(+2.5%) | $250.50 M(+2.5%) |
| Sept 2010 | - | $61.44 M(-7.4%) | $244.36 M(+2.0%) |
| June 2010 | - | $66.36 M(+11.1%) | $239.69 M(+2.1%) |
| Mar 2010 | - | $59.73 M(+5.1%) | $234.71 M(+3.8%) |
| Dec 2009 | $226.23 M(+1.6%) | $56.84 M(+0.1%) | $226.23 M(+3.1%) |
| Sept 2009 | - | $56.76 M(-7.5%) | $219.37 M(+2.4%) |
| June 2009 | - | $61.39 M(+19.8%) | $214.28 M(-4.5%) |
| Mar 2009 | - | $51.24 M(+2.5%) | $224.46 M(+0.5%) |
| Dec 2008 | $222.76 M(+25.7%) | $49.98 M(-3.3%) | $223.33 M(+0.8%) |
| Sept 2008 | - | $51.67 M(-27.8%) | $221.65 M(+2.5%) |
| June 2008 | - | $71.56 M(+42.8%) | $216.34 M(+15.4%) |
| Mar 2008 | - | $50.11 M(+3.7%) | $187.47 M(+5.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2007 | $177.28 M(+12.4%) | $48.30 M(+4.2%) | $177.28 M(+6.5%) |
| Sept 2007 | - | $46.36 M(+8.6%) | $166.53 M(+2.7%) |
| June 2007 | - | $42.69 M(+6.9%) | $162.15 M(-1.1%) |
| Mar 2007 | - | $39.92 M(+6.3%) | $164.04 M(+4.0%) |
| Dec 2006 | $157.75 M(+12.9%) | $37.55 M(-10.6%) | $157.75 M(+0.7%) |
| Sept 2006 | - | $41.99 M(-5.8%) | $156.66 M(+3.8%) |
| June 2006 | - | $44.58 M(+32.5%) | $150.93 M(+6.8%) |
| Mar 2006 | - | $33.63 M(-7.8%) | $141.38 M(+1.2%) |
| Dec 2005 | $139.70 M(+10.5%) | $36.46 M(+0.6%) | $139.70 M(+6.0%) |
| Sept 2005 | - | $36.26 M(+3.5%) | $131.75 M(+2.1%) |
| June 2005 | - | $35.02 M(+9.6%) | $129.02 M(+0.2%) |
| Mar 2005 | - | $31.95 M(+12.1%) | $128.80 M(+1.8%) |
| Dec 2004 | $126.46 M(+27.4%) | $28.51 M(-15.0%) | $126.46 M(+7.3%) |
| Sept 2004 | - | $33.53 M(-3.7%) | $117.91 M(+5.2%) |
| June 2004 | - | $34.80 M(+17.5%) | $112.08 M(+5.2%) |
| Mar 2004 | - | $29.61 M(+48.4%) | $106.54 M(+7.3%) |
| Dec 2003 | $99.28 M(+15.5%) | $19.96 M(-27.9%) | $99.28 M(-3.2%) |
| Sept 2003 | - | $27.70 M(-5.4%) | $102.59 M(+3.8%) |
| June 2003 | - | $29.27 M(+30.9%) | $98.87 M(+6.0%) |
| Mar 2003 | - | $22.36 M(-3.9%) | $93.31 M(+7.9%) |
| Dec 2002 | $85.94 M(+9.1%) | $23.26 M(-3.0%) | $86.51 M(+1.8%) |
| Sept 2002 | - | $23.98 M(+1.1%) | $84.94 M(+4.2%) |
| June 2002 | - | $23.71 M(+52.4%) | $81.49 M(+4.5%) |
| Mar 2002 | - | $15.56 M(-28.3%) | $78.00 M(-7.1%) |
| Dec 2001 | $78.78 M(+8.3%) | $21.69 M(+5.7%) | $83.93 M(+2.4%) |
| Sept 2001 | - | $20.53 M(+1.5%) | $81.97 M(+2.9%) |
| June 2001 | - | $20.22 M(-5.9%) | $79.68 M(+1.9%) |
| Mar 2001 | - | $21.49 M(+8.9%) | $78.18 M(+7.5%) |
| Dec 2000 | $72.73 M(+13.6%) | $19.73 M(+8.2%) | $72.73 M(+3.6%) |
| Sept 2000 | - | $18.24 M(-2.6%) | $70.20 M(+2.8%) |
| June 2000 | - | $18.72 M(+16.7%) | $68.26 M(+4.5%) |
| Mar 2000 | - | $16.04 M(-6.8%) | $65.34 M(+2.3%) |
| Dec 1999 | $64.00 M(+41.9%) | $17.20 M(+5.5%) | $63.90 M(+4.8%) |
| Sept 1999 | - | $16.30 M(+3.2%) | $61.00 M(+8.2%) |
| June 1999 | - | $15.80 M(+8.2%) | $56.40 M(+11.5%) |
| Mar 1999 | - | $14.60 M(+2.1%) | $50.60 M(+11.9%) |
| Dec 1998 | $45.10 M(+351.0%) | $14.30 M(+22.2%) | $45.20 M(+33.3%) |
| Sept 1998 | - | $11.70 M(+17.0%) | $33.90 M(+21.5%) |
| June 1998 | - | $10.00 M(+8.7%) | $27.90 M(+69.1%) |
| Mar 1998 | - | $9.20 M(+206.7%) | $16.50 M(+66.7%) |
| Dec 1997 | $10.00 M(-82.6%) | $3.00 M(-47.4%) | $9.90 M(-58.6%) |
| Sept 1997 | - | $5.70 M(-507.1%) | $23.90 M(-30.5%) |
| June 1997 | - | -$1.40 M(-153.8%) | $34.40 M(-28.8%) |
| Mar 1997 | - | $2.60 M(-84.7%) | $48.30 M(-15.9%) |
| Dec 1996 | $57.40 M(+48.7%) | $17.00 M(+4.9%) | $57.40 M(+11.5%) |
| Sept 1996 | - | $16.20 M(+29.6%) | $51.50 M(+12.2%) |
| June 1996 | - | $12.50 M(+6.8%) | $45.90 M(+7.0%) |
| Mar 1996 | - | $11.70 M(+5.4%) | $42.90 M(+10.9%) |
| Dec 1995 | $38.60 M(+41.4%) | $11.10 M(+4.7%) | $38.70 M(+7.5%) |
| Sept 1995 | - | $10.60 M(+11.6%) | $36.00 M(+11.8%) |
| June 1995 | - | $9.50 M(+26.7%) | $32.20 M(+9.9%) |
| Mar 1995 | - | $7.50 M(-10.7%) | $29.30 M(+7.7%) |
| Dec 1994 | $27.30 M(+54.2%) | $8.40 M(+23.5%) | $27.20 M(+7.9%) |
| Sept 1994 | - | $6.80 M(+3.0%) | $25.20 M(+9.1%) |
| June 1994 | - | $6.60 M(+22.2%) | $23.10 M(+12.7%) |
| Mar 1994 | - | $5.40 M(-15.6%) | $20.50 M(+14.5%) |
| Dec 1993 | $17.70 M(+105.8%) | $6.40 M(+36.2%) | $17.90 M(+29.7%) |
| Sept 1993 | - | $4.70 M(+17.5%) | $13.80 M(+17.9%) |
| June 1993 | - | $4.00 M(+42.9%) | $11.70 M(+15.8%) |
| Mar 1993 | - | $2.80 M(+21.7%) | $10.10 M(+16.1%) |
| Dec 1992 | $8.60 M(+138.9%) | $2.30 M(-11.5%) | $8.70 M(+8.8%) |
| Sept 1992 | - | $2.60 M(+8.3%) | $8.00 M(+27.0%) |
| June 1992 | - | $2.40 M(+71.4%) | $6.30 M(+37.0%) |
| Mar 1992 | - | $1.40 M(-12.5%) | $4.60 M(-51.6%) |
| Dec 1991 | $3.60 M | $1.60 M(+77.8%) | $9.50 M(+20.3%) |
| Sept 1991 | - | $900.00 K(+28.6%) | $7.90 M(+12.9%) |
| June 1991 | - | $700.00 K(-88.9%) | $7.00 M(+11.1%) |
| Mar 1991 | - | $6.30 M | $6.30 M |
FAQ
- What is IDEXX Laboratories annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for IDEXX Laboratories?
- What is IDEXX Laboratories annual EBITDA year-on-year change?
- What is IDEXX Laboratories quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for IDEXX Laboratories?
- What is IDEXX Laboratories quarterly EBITDA year-on-year change?
- What is IDEXX Laboratories TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for IDEXX Laboratories?
- What is IDEXX Laboratories TTM EBITDA year-on-year change?
What is IDEXX Laboratories annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of IDXX is $1.10 B
What is the all time high annual EBITDA for IDEXX Laboratories?
IDEXX Laboratories all-time high annual earnings before interest, taxes, depreciation & amortization is $1.10 B
What is IDEXX Laboratories annual EBITDA year-on-year change?
Over the past year, IDXX annual earnings before interest, taxes, depreciation & amortization has changed by +$85.40 M (+8.44%)
What is IDEXX Laboratories quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of IDXX is $340.74 M
What is the all time high quarterly EBITDA for IDEXX Laboratories?
IDEXX Laboratories all-time high quarterly earnings before interest, taxes, depreciation & amortization is $340.74 M
What is IDEXX Laboratories quarterly EBITDA year-on-year change?
Over the past year, IDXX quarterly earnings before interest, taxes, depreciation & amortization has changed by +$35.22 M (+11.53%)
What is IDEXX Laboratories TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of IDXX is $1.25 B
What is the all time high TTM EBITDA for IDEXX Laboratories?
IDEXX Laboratories all-time high TTM earnings before interest, taxes, depreciation & amortization is $1.25 B
What is IDEXX Laboratories TTM EBITDA year-on-year change?
Over the past year, IDXX TTM earnings before interest, taxes, depreciation & amortization has changed by +$57.57 M (+4.82%)